ArticlePloS one2021

Favorable prognosis of patients who received adjuvant androgen deprivation therapy after radiotherapy achieving undetectable levels of prostate-specific antigen in high- or very high-risk prostate cancer.

Jae-Uk Jeong et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.